Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1986;79(Suppl 12):38–43.

Current clinical management of hepatic problems in cystic fibrosis.

M S Tanner
PMCID: PMC1290126  PMID: 3522915

Full text

PDF
38

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alvarez F., Bernard O., Brunelle F., Hadchouel P., Odièvre M., Alagille D. Portal obstruction in children. I. Clinical investigation and hemorrhage risk. J Pediatr. 1983 Nov;103(5):696–702. doi: 10.1016/s0022-3476(83)80460-0. [DOI] [PubMed] [Google Scholar]
  2. Arborgh B., Eklund A., Norman A., Strandvik B. Urinary bile acid excretion in correlation to liver histopathology in cystic fibrosis. Scand J Gastroenterol. 1980;15(1):73–80. doi: 10.3109/00365528009181435. [DOI] [PubMed] [Google Scholar]
  3. BERNSTEIN J., VAWTER G., HARRIS G. B., YOUNG V., HILLMAN L. S. The occurrence of intestinal atresia in newborns with meconium ileus. The pathogenesis of an acquired anomaly. AMA J Dis Child. 1960 Jun;99:804–818. doi: 10.1001/archpedi.1960.02070030806016. [DOI] [PubMed] [Google Scholar]
  4. Bengmark S., Börjesson B., Hoevels J., Joelsson B., Lunderquist A., Owman T. Obliteration of esophageal varices by PTP: a follow-up of 43 patients. Ann Surg. 1979 Oct;190(4):549–554. doi: 10.1097/00000658-197910000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Beppu K., Inokuchi K., Koyanagi N., Nakayama S., Sakata H., Kitano S., Kobayashi M. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc. 1981 Nov;27(4):213–218. doi: 10.1016/s0016-5107(81)73224-3. [DOI] [PubMed] [Google Scholar]
  6. Burroughs A. K., Jenkins W. J., Sherlock S., Dunk A., Walt R. P., Osuafor T. O., Mackie S., Dick R. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1983 Dec 22;309(25):1539–1542. doi: 10.1056/NEJM198312223092502. [DOI] [PubMed] [Google Scholar]
  7. CONN H. O. Hazards attending the use of esophageal tamponade. N Engl J Med. 1958 Oct 9;259(15):701–707. doi: 10.1056/NEJM195810092591501. [DOI] [PubMed] [Google Scholar]
  8. Cello J. P., Grendell J. H., Crass R. A., Trunkey D. D., Cobb E. E., Heilbron D. C. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984 Dec 20;311(25):1589–1594. doi: 10.1056/NEJM198412203112501. [DOI] [PubMed] [Google Scholar]
  9. Cohen C., Olsen M. M. Pediatric total parenteral nutrition. Liver histopathology. Arch Pathol Lab Med. 1981 Mar;105(3):152–156. [PubMed] [Google Scholar]
  10. Conn H. O. Endoscopic sclerotherapy: an analysis of variants. Hepatology. 1983 Sep-Oct;3(5):769–771. doi: 10.1002/hep.1840030526. [DOI] [PubMed] [Google Scholar]
  11. Corrigan J. J., Jr, Taussig L. M., Beckerman R., Wagener J. S. Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. J Pediatr. 1981 Aug;99(2):254–257. doi: 10.1016/s0022-3476(81)80468-4. [DOI] [PubMed] [Google Scholar]
  12. Cunningham D. G., Churchill R. J., Reynes C. J. Computed tomography in the evaluation of liver disease in cystic fibrosis patients. J Comput Assist Tomogr. 1980 Apr;4(2):151–154. doi: 10.1097/00004728-198004000-00003. [DOI] [PubMed] [Google Scholar]
  13. Donnison A. B., Shwachman H., Gross R. E. A review of 164 children with meconium ileus seen at the Children's Hospital Medical Center, Boston. Pediatrics. 1966 May;37(5):833–850. [PubMed] [Google Scholar]
  14. Freeman J. G., Cobden I., Lishman A. H., Record C. O. Controlled trial of terlipressin ('Glypressin') versus vasopressin in the early treatment of oesophageal varices. Lancet. 1982 Jul 10;2(8289):66–68. doi: 10.1016/s0140-6736(82)91689-0. [DOI] [PubMed] [Google Scholar]
  15. Friedman H. Z., Langman C. B., Favus M. J. Vitamin D metabolism and osteomalacia in cystic fibrosis. Gastroenterology. 1985 Mar;88(3):808–813. doi: 10.1016/0016-5085(85)90156-8. [DOI] [PubMed] [Google Scholar]
  16. Grace N. D. Is sclerotherapy the treatment of choice for bleeding esophageal varices? Mayo Clin Proc. 1985 Mar;60(3):207–210. doi: 10.1016/s0025-6196(12)60223-7. [DOI] [PubMed] [Google Scholar]
  17. Graham N., Manhire A. R., Stead R. J., Lees W. R., Hodson M. E., Batten J. C. Cystic fibrosis: ultrasonographic findings in the pancreas and hepatobiliary system correlated with clinical data and pathology. Clin Radiol. 1985 Mar;36(2):199–203. doi: 10.1016/s0009-9260(85)80120-3. [DOI] [PubMed] [Google Scholar]
  18. HOLSCLAW D. S., ECKSTEIN H. B., NIXON H. H. MECONIUM ILEUS. A 20-YEAR REVIEW OF 109 CASES. Am J Dis Child. 1965 Feb;109:101–113. [PubMed] [Google Scholar]
  19. Hine K. R., Morris D., Toghill P., Dykes P. W. Fluorescein mixed with sclerosant improves the accuracy of endoscopic injection of oesophageal varices. Lancet. 1984 Aug 11;2(8398):322–323. doi: 10.1016/s0140-6736(84)92690-4. [DOI] [PubMed] [Google Scholar]
  20. Hughes C. A., Talbot I. C., Ducker D. A., Harran M. J. Total parenteral nutrition in infancy: effect on the liver and suggested pathogenesis. Gut. 1983 Mar;24(3):241–248. doi: 10.1136/gut.24.3.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Isenberg J. N. Cystic fibrosis: its influence on the liver, biliary tree, and bile salt metabolism. Semin Liver Dis. 1982 Nov;2(4):302–313. doi: 10.1055/s-2008-1040717. [DOI] [PubMed] [Google Scholar]
  22. Jenkins S. A., Baxter J. N., Corbett W., Devitt P., Ware J., Shields R. A prospective randomised controlled clinical trial comparing somatostatin and vasopressin in controlling acute variceal haemorrhage. Br Med J (Clin Res Ed) 1985 Jan 26;290(6464):275–278. doi: 10.1136/bmj.290.6464.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Johnson W. C., Widrich W. C., Ansell J. E., Robbins A. H., Nabseth D. C. Control of bleeding varices by vasopressin: a prospective randomized study. Ann Surg. 1977 Sep;186(3):369–376. doi: 10.1097/00000658-197709000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Johnston G. W., Rodgers H. W. A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices. Br J Surg. 1973 Oct;60(10):797–800. doi: 10.1002/bjs.1800601011. [DOI] [PubMed] [Google Scholar]
  25. Larcher V. F., Macdonald A., Vegnente A., Mowat A. P., Eddleston A. L., Williams R. Antibodies to liver-specific lipoprotein in children with chronic liver disease due to "autoimmune" chronic active hepatitis, cystic fibrosis, and alpha 1-antitrypsin deficiency. J Pediatr Gastroenterol Nutr. 1984 Nov;3(5):728–733. doi: 10.1097/00005176-198411000-00016. [DOI] [PubMed] [Google Scholar]
  26. Lebrec D., De Fleury P., Rueff B., Nahum H., Benhamou J. P. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980 Dec;79(6):1139–1144. [PubMed] [Google Scholar]
  27. Lebrec D., Poynard T., Hillon P., Benhamou J. P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med. 1981 Dec 3;305(23):1371–1374. doi: 10.1056/NEJM198112033052302. [DOI] [PubMed] [Google Scholar]
  28. Lunderquist A., Vang J. Transhepatic catheterization and obliteration of the coronary vein in patients with portal hypertension and esophageal varices. N Engl J Med. 1974 Sep 26;291(13):646–649. doi: 10.1056/NEJM197409262911303. [DOI] [PubMed] [Google Scholar]
  29. MacDougall B. R., Westaby D., Theodossi A., Dawson J. L., Williams R. Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet. 1982 Jan 16;1(8264):124–127. doi: 10.1016/s0140-6736(82)90378-6. [DOI] [PubMed] [Google Scholar]
  30. Mazer M., Smith C. W., Martin V. N. Distal splenic artery embolization with a flow-directed balloon catheter. Radiology. 1985 Jan;154(1):245–245. doi: 10.1148/radiology.154.1.3964943. [DOI] [PubMed] [Google Scholar]
  31. McCormack T., Martin T., Smallwood R. H., Robinson P., Walton L., Johnson A. G. Doppler ultrasound probe for assessment of blood-flow in oesophageal varices. Lancet. 1983 Mar 26;1(8326 Pt 1):677–678. doi: 10.1016/s0140-6736(83)91971-2. [DOI] [PubMed] [Google Scholar]
  32. Mieli-Vergani G., Psacharopoulos H. T., Nicholson A. M., Eddleston A. L., Mowat A. P., Williams R. Immune responses to liver membrane antigens in patients with cystic fibrosis and liver disease. Arch Dis Child. 1980 Sep;55(9):696–701. doi: 10.1136/adc.55.9.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Mozes M. F., Spigos D. G., Pollak R., Abejo R., Pavel D. G., Tan W. S., Jonasson O. Partial splenic embolization, an alternative to splenectomy--results of a prospective, randomized study. Surgery. 1984 Oct;96(4):694–702. [PubMed] [Google Scholar]
  34. NACHLAS M. M. Experiences with the triple-lumen single-balloon tube in massive upper gastrointestinal hemorrhage. Gastroenterology. 1956 Jun;30(6):913–928. [PubMed] [Google Scholar]
  35. Oppenheimer E. H., Esterly J. R. Hepatic changes in young infants with cystic fibrosis: possible relation to focal biliary cirrhosis. J Pediatr. 1975 May;86(5):683–689. doi: 10.1016/s0022-3476(75)80351-9. [DOI] [PubMed] [Google Scholar]
  36. Ozsoylu S., Koçak N., Yüce A. Propranolol therapy for portal hypertension in children. J Pediatr. 1985 Feb;106(2):317–321. doi: 10.1016/s0022-3476(85)80316-4. [DOI] [PubMed] [Google Scholar]
  37. PALMER E. D., BRICK I. B. Correlation between the severity of esophageal varices in portal cirrhosis and their propensity toward hemorrhage. Gastroenterology. 1956 Jan;30(1):85–90. [PubMed] [Google Scholar]
  39. Paquet K. J. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy. 1982 Jan;14(1):4–5. doi: 10.1055/s-2007-1021560. [DOI] [PubMed] [Google Scholar]
  40. Park R. W., Grand R. J. Gastrointestinal manifestations of cystic fibrosis: a review. Gastroenterology. 1981 Dec;81(6):1143–1161. [PubMed] [Google Scholar]
  41. REYNOLDS T. B., REDEKER A. G., GELLER H. M. Wedged hepatic venous pressure; a clinical evaluation. Am J Med. 1957 Mar;22(3):341–350. doi: 10.1016/0002-9343(57)90090-6. [DOI] [PubMed] [Google Scholar]
  42. Resnick R. H., Chalmers T. C., Ishihara A. M., Garceau A. J., Callow A. D., Schimmel E. M., O'Hara E. T. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med. 1969 Apr;70(4):675–688. doi: 10.7326/0003-4819-70-4-675. [DOI] [PubMed] [Google Scholar]
  43. Reynolds T. B. What to do about esophageal varices? N Engl J Med. 1983 Dec 22;309(25):1575–1577. doi: 10.1056/NEJM198312223092510. [DOI] [PubMed] [Google Scholar]
  44. Richardson V. F., Robertson C. F., Mowat A. P., Howard E. R., Price J. F. Deterioration in lung function after general anaesthesia in patients with cystic fibrosis. Acta Paediatr Scand. 1984 Jan;73(1):75–79. doi: 10.1111/j.1651-2227.1984.tb09901.x. [DOI] [PubMed] [Google Scholar]
  45. Roy C. C., Weber A. M., Morin C. L., Lepage G., Brisson G., Yousef I., Lasalle R. Hepatobiliary disease in cystic fibrosis: a survey of current issues and concepts. J Pediatr Gastroenterol Nutr. 1982;1(4):469–478. doi: 10.1097/00005176-198212000-00005. [DOI] [PubMed] [Google Scholar]
  46. Sarin S. K., Sachdeva G. K., Nanda R., Vij J. C., Anand B. S. Endoscopic sclerotherapy using absolute alcohol. Gut. 1985 Feb;26(2):120–124. doi: 10.1136/gut.26.2.120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Schuster S. R., Shwachman H., Toyama W. M., Rubino A., Taik-Khaw K. The management of portal hypertension in cystic fibrosis. J Pediatr Surg. 1977 Apr;12(2):201–206. doi: 10.1016/s0022-3468(77)80008-0. [DOI] [PubMed] [Google Scholar]
  48. Seidman E., Weber A. M., Morin C. L., Ethier R., Lamarche J. B., Guerguérian A. J., Geoffroy G., Roy C. C. Spinal cord paralysis following sclerotherapy for esophageal varices. Hepatology. 1984 Sep-Oct;4(5):950–954. doi: 10.1002/hep.1840040528. [DOI] [PubMed] [Google Scholar]
  49. Stamatakis J. D., Howard E. R., Psacharopoulos H. T., Mowat A. P. Injection sclerotherapy for oesophageal varices in children. Br J Surg. 1982 Feb;69(2):74–75. doi: 10.1002/bjs.1800690205. [DOI] [PubMed] [Google Scholar]
  50. Strandvik B., Samuelson K. Fasting serum bile acid levels in relation to liver histopathology in cystic fibrosis. Scand J Gastroenterol. 1985 Apr;20(3):381–384. doi: 10.3109/00365528509091668. [DOI] [PubMed] [Google Scholar]
  51. Terblanche J., Bornman P. C., Kirsch R. E. Sclerotherapy for bleeding esophageal varices. Annu Rev Med. 1984;35:83–94. doi: 10.1146/annurev.me.35.020184.000503. [DOI] [PubMed] [Google Scholar]
  52. Terblanche J. The long-term management of patients after an oesophageal variceal bleed: the role of sclerotherapy. Br J Surg. 1985 Feb;72(2):88–90. doi: 10.1002/bjs.1800720204. [DOI] [PubMed] [Google Scholar]
  53. Terblanche J. Treatment of esophageal varices by injection sclerotherapy. Adv Surg. 1981;15:257–291. [PubMed] [Google Scholar]
  54. Terblanche J., Yakoob H. I., Bornman P. C., Stiegmann G. V., Bane R., Jonker M., Wright J., Kirsch R. Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy. Ann Surg. 1981 Oct;194(4):521–530. doi: 10.1097/00000658-198110000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Tyson K. R., Schuster S. R., Shwachman H. Portal hypertension in cystic fibrosis. J Pediatr Surg. 1968 Apr;3(2):271–277. doi: 10.1016/0022-3468(68)90011-0. [DOI] [PubMed] [Google Scholar]
  56. Viallet A., Marleau D., Huet M., Martin F., Farley A., Villeneuve J. P., Lavoie P. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975 Dec;69(6):1297–1300. [PubMed] [Google Scholar]
  57. Warren W. D., Millikan W. J., Jr, Henderson J. M., Wright L., Kutner M., Smith R. B., 3rd, Fulenwider J. T., Salam A. A., Galambos J. T. Ten years portal hypertensive surgery at Emory. Results and new perspectives. Ann Surg. 1982 May;195(5):530–542. doi: 10.1097/00000658-198205000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Wilson-Sharp R. C., Irving H. C., Brown R. C., Chalmers D. M., Littlewood J. M. Ultrasonography of the pancreas, liver, and biliary system in cystic fibrosis. Arch Dis Child. 1984 Oct;59(10):923–926. doi: 10.1136/adc.59.10.923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Witte C. L., Witte M. H., Renert W., O'Mara R. E., Lilien D. L. Splenic artery ligation in selected patients with hepatic cirrhosis and in Sprague-Dawley rats. Surg Gynecol Obstet. 1976 Jan;142(1):1–12. [PubMed] [Google Scholar]
  60. el-Khishen M. A., Henderson J. M., Millikan W. J., Jr, Kutner M. H., Warren W. D. Splenectomy is contraindicated for thrombocytopenia secondary to portal hypertension. Surg Gynecol Obstet. 1985 Mar;160(3):233–238. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES